{"disease":{"id":"acute-gvhd","name":"acute gvhd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05263999","title":"A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":158,"lead_sponsor_name":"Equillium","has_results":false},{"nct_id":"NCT04373057","title":"Prebiotic Galacto-oligosaccharide and Acute GVHD","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":128,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03846479","title":"Itacitinib for Low Risk GVHD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"John Levine","has_results":true},{"nct_id":"NCT04014790","title":"RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Regimmune Corporation","has_results":true},{"nct_id":"NCT04645667","title":"Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)","phase":"","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT06462365","title":"Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Tr1X, Inc.","has_results":false},{"nct_id":"NCT03763318","title":"A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Equillium","has_results":true},{"nct_id":"NCT04033627","title":"TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Shanghai Children's Medical Center","has_results":false},{"nct_id":"NCT02245412","title":"A Phase 2A Study of ALXN1007 in Participants With Newly Diagnosed Acute Lower Gastrointestinal Graft-Versus-Host Disease","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT02611180","title":"Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":22,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT05401955","title":"Physiotherapy and Therapeutic Exercise Program in Graft-versus-host Disease (GvHD)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"University of Salamanca","has_results":false},{"nct_id":"NCT06321198","title":"A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD","phase":"NA","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Anhui Provincial Hospital","has_results":false},{"nct_id":"NCT04139577","title":"FMT In High-Risk Acute GVHD After ALLO HCT","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT01757197","title":"Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":true},{"nct_id":"NCT03701698","title":"Ruxolitinib and Steroid As First Line Therapy for Acute GVHD","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT04768907","title":"Early Access Program With MaaT013 in Steroid-refractory Acute Gastrointestinal Graft Versus Host Disease","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"MaaT Pharma","has_results":false},{"nct_id":"NCT04745637","title":"Managed Access Programs for INC424, Ruxolitinib","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}